Table 3.

KEGG analysis of partial results.

Terms	Count	p value	Genes
hsa05200: Pathways in cancer	21	4.52e − 03	SMAD2, GSK3B, SMAD4, HDAC2, CHUK, GADD45A, IL15, DLL1, RASGRP1, EPOR, GNAI1, AGT, MAPK8, CCND1, GNG7, COL4A5, KRAS, VHL, JAK2, SOS2, and FGFR2
hsa04010: MAPK signaling pathway	15	2.25e − 03	MEF2C, MAP3K1, CHUK, GADD45A, CACNA2D1, RRAS2, RASGRP1, RAP1B, MAPK8, RASA2, MKNK2, KRAS, LAMTOR3, SOS2, and FGFR2
hsa04151: PI3K-Akt signaling pathway	13	5.15e − 02	GSK3B, CHUK, YWHAZ, EPOR, CCND1, PPP2R5E, GNG7, COL4A5, KRAS, JAK2, SOS2, FGFR2, and MCL1
hsa04014: Ras signaling pathway	11	1.79e − 02	RAP1B, RAB5B, MAPK8, CHUK, GNG7, RASA2, RRAS2, KRAS, RASGRP1, SOS2, and FGFR2
hsa05224: Breast cancer	7	7.44e − 02	GSK3B, CCND1, GADD45A, TNFSF11, KRAS, DLL1, and SOS2